{"disease":{"id":"gbm","name":"gbm"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06717295","title":"The CCANED-CIPHER Study: Early Cancer Detection and Treatment Response Monitoring Using AI-Based Platelet and Immune Cell Transcriptomic Profiling","phase":"","overall_status":"RECRUITING","enrollment_count":6000,"lead_sponsor_name":"Javier Toledo","has_results":false},{"nct_id":"NCT06914700","title":"A Nomogram for Predicting the Diagnosis of Central Malignant Tumors Based on Preoperative Clinical Characteristics and Laboratory Indicators:","phase":"","overall_status":"COMPLETED","enrollment_count":800,"lead_sponsor_name":"Guangdong Provincial People's Hospital","has_results":false},{"nct_id":"NCT05902169","title":"Sonocloud-9 in Association With Carboplatin Versus Standard-of-Care Chemotherapies (CCNU or TMZ) in Recurrent GBM","phase":"PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":560,"lead_sponsor_name":"CarThera","has_results":false},{"nct_id":"NCT05271240","title":"Repeated Superselective Intraarterial Cerebral Infusion (SIACI) of Bevacizumab With Temozolomide and Radiation Compared to Temozolomide and Radiation Alone in Newly Diagnosed GBM","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":432,"lead_sponsor_name":"Northwell Health","has_results":false},{"nct_id":"NCT07130149","title":"Sonodynamic-Chemoradiotherapy Integration in Glioblastoma","phase":"PHASE2","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":230,"lead_sponsor_name":"Yingjuan Zheng","has_results":false},{"nct_id":"NCT03758014","title":"Studies of Chlorogenic Acid for Injection for Safety and Efficacy of Grade IV GBM Patients","phase":"PHASE2, PHASE3","overall_status":"UNKNOWN","enrollment_count":200,"lead_sponsor_name":"Sichuan J.Z. Bio-chemical Science and Technology Development Co., Ltd","has_results":false},{"nct_id":"NCT06630260","title":"5G-RUBY: Avutometinib and Defactinib in Malignant Brain Tumours","phase":"PHASE1, PHASE2","overall_status":"RECRUITING","enrollment_count":182,"lead_sponsor_name":"Institute of Cancer Research, United Kingdom","has_results":false},{"nct_id":"NCT07409584","title":"Mental Health and Suicidality in Glioblastoma Patients in Germany","phase":"","overall_status":"RECRUITING","enrollment_count":176,"lead_sponsor_name":"University Hospital, Essen","has_results":false},{"nct_id":"NCT05933265","title":"Study of LP-184 in Patients With Advanced Solid Tumors","phase":"PHASE1, PHASE2","overall_status":"RECRUITING","enrollment_count":175,"lead_sponsor_name":"Lantern Pharma Inc.","has_results":false},{"nct_id":"NCT02465268","title":"Vaccine Therapy for the Treatment of Newly Diagnosed Glioblastoma Multiforme","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":175,"lead_sponsor_name":"University of Florida","has_results":true},{"nct_id":"NCT05086497","title":"WBSI Guided Personalized Delivery of TTFields","phase":"NA","overall_status":"RECRUITING","enrollment_count":155,"lead_sponsor_name":"Abramson Cancer Center at Penn Medicine","has_results":false},{"nct_id":"NCT02974738","title":"A Trial of Belzutifan (PT2977, MK-6482) Tablets In Patients With Advanced Solid Tumors (MK-6482-001)","phase":"PHASE1","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":120,"lead_sponsor_name":"Peloton Therapeutics, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)","has_results":false},{"nct_id":"NCT02717962","title":"Study of VAL-083 in Patients With MGMT Unmethylated, Bevacizumab-naive Glioblastoma in the Adjuvant or Recurrent Setting","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":118,"lead_sponsor_name":"Kintara Therapeutics, Inc.","has_results":false},{"nct_id":"NCT06989086","title":"FearLess in NeuroOncology","phase":"NA","overall_status":"RECRUITING","enrollment_count":112,"lead_sponsor_name":"Virginia Commonwealth University","has_results":false},{"nct_id":"NCT06690216","title":"Evaluation of [18F]AlF-NOTA-PCP2 PET/CT for PD-L1 Detection in Malignant Tumors","phase":"PHASE1, PHASE2","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":100,"lead_sponsor_name":"Man Hu","has_results":false},{"nct_id":"NCT03025893","title":"A Phase II/III Study of High-dose, Intermittent Sunitinib in Patients With Recurrent Glioblastoma Multiforme","phase":"PHASE2, PHASE3","overall_status":"UNKNOWN","enrollment_count":100,"lead_sponsor_name":"Amsterdam UMC, location VUmc","has_results":false},{"nct_id":"NCT06781372","title":"Patient's Derived Organoids for Drug Screening in Glioblastoma","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":100,"lead_sponsor_name":"Fondazione Policlinico Universitario Agostino Gemelli IRCCS","has_results":false},{"nct_id":"NCT06939400","title":"Photodynamic Therapy for Glioblastoma Multiforme Based on Metaverse and Yellow Fluorescence","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":100,"lead_sponsor_name":"Zhejiang Provincial People's Hospital","has_results":false},{"nct_id":"NCT04587830","title":"ADI-PEG 20 Plus Radiotherapy and Temozolomide in Subjects With Glioblastoma Multiforme","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":100,"lead_sponsor_name":"Polaris Group","has_results":false},{"nct_id":"NCT07203404","title":"A Study of Anti-CD19/BCMA Universal CAR-T Cell Therapy RD06-05 in Patients With Autoimmune Diseases.","phase":"EARLY_PHASE1","overall_status":"RECRUITING","enrollment_count":84,"lead_sponsor_name":"Nanjing Bioheng Biotech Co., Ltd.","has_results":false},{"nct_id":"NCT06521567","title":"A Study of Cobolimab Plus Dostarlimab in Pediatric and Young Adult Participants With Cancer","phase":"PHASE1, PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":83,"lead_sponsor_name":"GlaxoSmithKline","has_results":false},{"nct_id":"NCT06926075","title":"Early Phase Study of KESONOTIDE™in Participants With Solid Tumours","phase":"PHASE1, PHASE2","overall_status":"RECRUITING","enrollment_count":80,"lead_sponsor_name":"Filamon LTD","has_results":false},{"nct_id":"NCT06538428","title":"Methylation Patterns of the NUPR1, MGMT, NDRG2, and GLI1 Genes and Their Impact on Therapeutic Outcome of GBM Patients","phase":"","overall_status":"COMPLETED","enrollment_count":78,"lead_sponsor_name":"Ain Shams University","has_results":false},{"nct_id":"NCT07431216","title":"A Phase 1b/2a Study to Evaluate the Safety, Pharmacokinetics, and Objective Response of STAR-001 (LP-184) in Combination With Spironolactone in Supratentorial Glioblastoma at First Progression","phase":"PHASE1, PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":68,"lead_sponsor_name":"Starlight Therapeutics Inc.","has_results":false},{"nct_id":"NCT05879367","title":"Evaluation of Eflornithine Plus Temozolomide in Patients With Newly Diagnosed Glioblastoma or Astrocytoma","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":66,"lead_sponsor_name":"Orbus Therapeutics, Inc.","has_results":false},{"nct_id":"NCT07391215","title":"5G-PEARL: Paxalisib in Malignant Brain Tumours","phase":"PHASE1, PHASE2","overall_status":"RECRUITING","enrollment_count":64,"lead_sponsor_name":"Institute of Cancer Research, United Kingdom","has_results":false},{"nct_id":"NCT03782415","title":"Study to Evaluate Ibudilast and TMZ Combo Treatment in Newly Diagnosed and Recurrent Glioblastoma","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":64,"lead_sponsor_name":"MediciNova","has_results":false},{"nct_id":"NCT04606316","title":"Surgical Nivolumab And Ipilimumab For Recurrent GBM","phase":"PHASE1","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":63,"lead_sponsor_name":"Patrick Wen, MD","has_results":false},{"nct_id":"NCT01491893","title":"PVSRIPO for Recurrent Glioblastoma (GBM)","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":61,"lead_sponsor_name":"Istari Oncology, Inc.","has_results":true},{"nct_id":"NCT03746288","title":"To Evaluate the Efficacy and Safety of CAN008 Combined With Re-irradiation (rRT) for Treating Patients With Recurrent Glioblastoma (GBM)","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":60,"lead_sponsor_name":"CANbridge Life Sciences Ltd.","has_results":false},{"nct_id":"NCT06649851","title":"G-CSF After Chemo-radiation in Patients With Glioblastoma","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":60,"lead_sponsor_name":"Massachusetts General Hospital","has_results":false},{"nct_id":"NCT04528680","title":"Ultrasound-based Blood-brain Barrier Opening and Albumin-bound Paclitaxel and Carboplatin for Recurrent Glioblastoma","phase":"PHASE1, PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":57,"lead_sponsor_name":"Northwestern University","has_results":false},{"nct_id":"NCT06835803","title":"Enhanced Local Intensified Radiation Therapy in Elderly Glioblastoma: A Phase 2 Hybrid Randomized Trial","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":56,"lead_sponsor_name":"Brigham and Women's Hospital","has_results":false},{"nct_id":"NCT06616727","title":"The Safety and Efficacy of SNC-109 CAR-T Cells Therapy the rGBM","phase":"PHASE1","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":50,"lead_sponsor_name":"Shanghai Simnova Biotechnology Co.,Ltd.","has_results":false},{"nct_id":"NCT01870726","title":"Safety and Efficacy of INC280 and Buparlisib (BKM120) in Patients With Recurrent Glioblastoma","phase":"PHASE1, PHASE2","overall_status":"TERMINATED","enrollment_count":43,"lead_sponsor_name":"Novartis Pharmaceuticals","has_results":true},{"nct_id":"NCT04391595","title":"LY3214996 Plus Abemaciclib in Recurrent Glioblastoma Patients","phase":"EARLY_PHASE1","overall_status":"COMPLETED","enrollment_count":42,"lead_sponsor_name":"Nader Sanai","has_results":false},{"nct_id":"NCT05431348","title":"Effect of stRess and exeRcize on the Outcome After Chemo-Radiation","phase":"","overall_status":"COMPLETED","enrollment_count":42,"lead_sponsor_name":"Maastricht Radiation Oncology","has_results":false},{"nct_id":"NCT07472387","title":"Impact of Androgen Signaling on the Composition of the Immune Microenvironment in Glioblastomas","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":40,"lead_sponsor_name":"Assistance Publique - Hôpitaux de Paris","has_results":false},{"nct_id":"NCT06092255","title":"A Study of SVZ Irradiation With Postoperative Radiotherapy in Patients With GBM.","phase":"NA","overall_status":"UNKNOWN","enrollment_count":40,"lead_sponsor_name":"Jiangsu Cancer Institute & Hospital","has_results":false},{"nct_id":"NCT07455045","title":"A Phase I Study of FZ-AD005 in Patients With High-Grade Glioma (HGG)","phase":"PHASE1","overall_status":"NOT_YET_RECRUITING","enrollment_count":40,"lead_sponsor_name":"Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd.","has_results":false},{"nct_id":"NCT07416188","title":"Novel Indenoisoquinolone CMYC/TOPOISOMERASE 1 Inhibitor (LMP744) in Recurrent Glioblastoma","phase":"PHASE1, PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":40,"lead_sponsor_name":"National Institute of Neurological Disorders and Stroke (NINDS)","has_results":false},{"nct_id":"NCT07193654","title":"Stupp Treatment With Intrathecal Injection of Thiotepa for Glioblastoma With Advanced Spread","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":38,"lead_sponsor_name":"Second Affiliated Hospital, School of Medicine, Zhejiang University","has_results":false},{"nct_id":"NCT07511725","title":"Prophylactic Regimen With Intrathecal Thiotepa in SVZ-positive or Meningeal-risk Glioblastoma","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":38,"lead_sponsor_name":"Second Affiliated Hospital, School of Medicine, Zhejiang University","has_results":false},{"nct_id":"NCT07366892","title":"Leica Microsystems Sponsored PMCF Study to Collect and Confirm Clinical Data on the Performance of the GLOW400 Device When Used in Accordance With Its Intended Use","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":37,"lead_sponsor_name":"Leica Microsystems (Schweiz) AG","has_results":false},{"nct_id":"NCT07244666","title":"Safety and Preliminary Efficacy of a Metabolically Armed Chimeric Antigen Receptor T Cell Therapy Targeting EGFRvIII for Recurrent Glioblastoma","phase":"EARLY_PHASE1","overall_status":"NOT_YET_RECRUITING","enrollment_count":36,"lead_sponsor_name":"Second Affiliated Hospital, School of Medicine, Zhejiang University","has_results":false},{"nct_id":"NCT07120620","title":"PriCoTTF Study: TTFields Before and During Radiotherapy for Newly Diagnosed Glioblastoma","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":33,"lead_sponsor_name":"Sied Kebir","has_results":false},{"nct_id":"NCT05954858","title":"Surgical Tissue Flap to Bypass the Blood Brain Barrier in Glioblastoma","phase":"NA","overall_status":"RECRUITING","enrollment_count":32,"lead_sponsor_name":"Northwell Health","has_results":false},{"nct_id":"NCT03050736","title":"Safety Study of VAL-083 and Radiotherapy in Patients With Newly Diagnosed GBM Having Unmethylated MGMT Expression","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":29,"lead_sponsor_name":"Kintara Therapeutics, Inc.","has_results":false},{"nct_id":"NCT06018363","title":"Clinical Study on the Treatment of Malignant Brain Glioma by QH104 Cell Injection","phase":"PHASE1, PHASE2","overall_status":"RECRUITING","enrollment_count":25,"lead_sponsor_name":"Dushu Lake Hospital Affiliated to Soochow University","has_results":false},{"nct_id":"NCT06396481","title":"Clinical Study of Allogeneic Vγ9Vδ2 T Cells in the Treatment of Brain Malignant Glioma","phase":"EARLY_PHASE1","overall_status":"NOT_YET_RECRUITING","enrollment_count":25,"lead_sponsor_name":"Beijing Tiantan Hospital","has_results":false}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}